|
rhodiola rosea as a prepared product solution combines the genuine Rhodiola Rosea L. drug from controlled, integrated cultivation of plants with extract FB300A for the final, modern film tablet. The documentation package in CTD format is available as a significant source of added value. This provides the documentary basis for registration and comfortable market access (Directive 2004/24/EC) in Europe. Market access beyond Europe is possible as well, thanks to our expertise with respect to rhodiola rosea.
|